Literature DB >> 8499794

[The pneumococcal vaccine. Its efficacy in patients 55 and over].

R Marchand1.   

Abstract

Three recent articles are examined in which research using the double-blind randomised clinical trial, the case control study, and the quasi-cohort study is described. Understanding the advantages and disadvantages of these methods makes it easier to grasp the pneumococcal vaccine controversy and make an informed choice.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8499794      PMCID： PMC2379665     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  10 in total

1.  PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA.

Authors:  R AUSTRIAN; J GOLD
Journal:  Ann Intern Med       Date:  1964-05       Impact factor: 25.391

2.  The pneumococcus at Hopkins: early portents of future developments.

Authors:  R Austrian
Journal:  Johns Hopkins Med J       Date:  1979-06

Review 3.  Resolving the pneumococcal vaccine controversy: are there alternatives to randomized clinical trials?

Authors:  J D Clemens; E D Shapiro
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct

Review 4.  Pneumococcus: the first one hundred years.

Authors:  R Austrian
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

5.  Response of patients with Hodgkin's disease to pneumococcal vaccine.

Authors:  D R Minor; G Schiffman; L S McIntosh
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

6.  The clinical effectiveness of pneumococcal vaccine in the elderly.

Authors:  R V Sims; W C Steinmann; J H McConville; L R King; W C Zwick; J S Schwartz
Journal:  Ann Intern Med       Date:  1988-05       Impact factor: 25.391

7.  Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study.

Authors:  M S Simberkoff; A P Cross; M Al-Ibrahim; A L Baltch; P J Geiseler; J Nadler; A S Richmond; R P Smith; G Schiffman; D S Shepard
Journal:  N Engl J Med       Date:  1986-11-20       Impact factor: 91.245

8.  Pneumococcal vaccine in the United States. A critical analysis.

Authors:  J V Hirschmann; B A Lipsky
Journal:  JAMA       Date:  1981-09-25       Impact factor: 56.272

9.  The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

Authors:  E D Shapiro; A T Berg; R Austrian; D Schroeder; V Parcells; A Margolis; R K Adair; J D Clemens
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

10.  Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine.

Authors:  C V Broome; R R Facklam; D W Fraser
Journal:  N Engl J Med       Date:  1980-09-04       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.